Works matching IS 00281298 AND DT 2013 AND VI 386 AND IP 2
Results: 6
Interaction of D preferring agonist (−)- N-(2-(4-(biphenyl-4-yl)piperazin-1-yl)ethyl)- N-propyl-4,5,6,7-tetrahydrobenzo[ d]thiazole-2,6-diamine (D-264) with cloned human D, D, and D receptors: potent stimulation of mitogen-activated protein kinases and G protein-coupled inward rectifier potassium channels
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, v. 386, n. 2, p. 97, doi. 10.1007/s00210-012-0811-6
- By:
- Publication type:
- Article
Dopamine D receptor antagonism-still a therapeutic option for the treatment of schizophrenia.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, v. 386, n. 2, p. 155, doi. 10.1007/s00210-012-0806-3
- By:
- Publication type:
- Article
Direct and indirect interactions of the dopamine D receptor with glutamate pathways: implications for the treatment of schizophrenia.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, v. 386, n. 2, p. 107, doi. 10.1007/s00210-012-0797-0
- By:
- Publication type:
- Article
Agonist high- and low-affinity states of dopamine D receptors: methods of detection and clinical implications.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, v. 386, n. 2, p. 135, doi. 10.1007/s00210-012-0817-0
- By:
- Publication type:
- Article
Pergolide block of the cloned Kv1.5 potassium channels.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, v. 386, n. 2, p. 125, doi. 10.1007/s00210-012-0776-5
- By:
- Publication type:
- Article
Rationale in support of the use of selective dopamine D receptor antagonists for the pharmacotherapeutic management of substance use disorders.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, v. 386, n. 2, p. 167, doi. 10.1007/s00210-012-0803-6
- By:
- Publication type:
- Article